GO:0140469 GCN2-mediated signaling: Amino Acid Starvation Stress Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140469 (GCN2-mediated signaling) describes the intracellular signaling cascade triggered when the kinase GCN2 (gene EIF2AK4) is activated by stress signals such as amino acid starvation.
• GCN2 is activated by uncharged tRNAs and by ribosome collisions, which serve as sensors of translation stress and trigger the integrated stress response (ISR).
• Activated GCN2 phosphorylates the translation initiation factor eIF2alpha, leading to global translation attenuation while selectively promoting translation of stress-responsive mRNAs.
• The GCN2 pathway is conserved from yeast to humans and is central to cell fate decisions under nutrient stress, influencing survival, apoptosis, and immune signaling.
• Dysregulation of GCN2-mediated signaling is implicated in cancer, cardiotoxicity, inflammatory diseases, and metabolic disorders, making it a therapeutic target.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of GCN2 pathway components and their roles in disease.
Description
GCN2-mediated signaling (GO:0140469) is a biological process in which the intracellular kinase GCN2, encoded by the EIF2AK4 gene, transmits stress signals to downstream effectors to reprogram cellular translation and gene expression. This pathway is a core branch of the integrated stress response (ISR) and is activated by diverse stressors, most notably amino acid starvation, but also by ribosome collisions and mitochondrial dysfunction. Upon activation, GCN2 phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha), which reduces global protein synthesis while enhancing the translation of specific stress-responsive mRNAs, such as that encoding the transcription factor ATF4. This dual translational control allows cells to adapt to nutrient limitation or to commit to apoptosis when stress is unresolved. Researchers study GCN2-mediated signaling to understand how cells sense and respond to metabolic stress, how this pathway contributes to immune responses, and how its dysregulation drives diseases including cancer, cardiotoxicity, and inflammatory conditions. The pathway is highly conserved and serves as a paradigm for signal transduction via translational control. Recent structural and functional studies have revealed how GCN2 is regulated by its pseudokinase domain and by interacting proteins, offering new opportunities for pharmacological intervention. This article provides a comprehensive overview of GO:0140469, covering its definition, mechanism, key genes, disease relevance, and experimental models, with a focus on CRISPR-based approaches for functional genomics.
GCN2-mediated signaling At A Glance
| GO ID | GO:0140469 |
|---|---|
| GO term | GCN2-mediated signaling |
| Ontology | biological_process |
| Synonym | EIF2AK4-mediated signaling; regulation of eIF2 alpha phosphorylation by amino acid starvation |
| Major function | Transduces stress signals via GCN2 kinase to phosphorylate eIF2alpha, leading to translational reprogramming and cell fate decisions. |
| Key kinase | GCN2 (EIF2AK4), a serine/threonine kinase activated by uncharged tRNAs and ribosome collisions. |
| Downstream target | eIF2alpha (EIF2S1), whose phosphorylation inhibits global translation but promotes stress-responsive mRNA translation. |
| Stress inducers | Amino acid starvation, ribosome collisions, mitochondrial injury, and nitric oxide. |
| Pathway context | A branch of the integrated stress response (ISR) that cross-talks with mTORC1 signaling. |
What Is GO:0140469?
GCN2-mediated signaling (GO:0140469) is defined as a series of reactions in which a signal is passed on to downstream proteins within the cell via GCN2 (also known as EIF2AK4), an intracellular protein kinase that is activated by stress signals, such as amino acid starvation. This process involves the detection of stress, activation of GCN2 kinase activity, phosphorylation of eIF2alpha, and subsequent changes in translation and gene expression that allow the cell to adapt or undergo apoptosis.
Why Is GCN2-mediated signaling Important in Cell Biology?
GCN2-mediated signaling is critical for cellular adaptation to nutrient stress and for maintaining proteostasis. It is a central node in the integrated stress response, influencing cell survival, immune function, and metabolism. Dysregulation of this pathway contributes to cancer progression, cardiotoxicity, inflammatory diseases, and metabolic disorders, making it a high-value target for therapeutic development and a key area for functional genomics research.
• Controls global protein synthesis and selective translation of stress-responsive mRNAs during amino acid starvation.
• Acts as a sensor of ribosome collisions, linking translation quality control to stress signaling.
• Regulates cell fate decisions, including survival, apoptosis, and senescence, under stress conditions.
• Plays a role in immune responses, including pattern-triggered immunity in plants and proinflammatory signaling in mammals.
• Implicated in cancer biology, where GCN2 can promote tumor adaptation to nutrient-poor microenvironments.
• Contributes to drug-induced cardiotoxicity, such as ponatinib-induced cardiac damage.
• Involved in metabolic regulation, including glutamine sensing and bone anabolism.
• Provides a mechanism for cross-talk between mTORC1 and the ISR.
• Serves as a target for small-molecule inhibitors and activators in therapeutic development.
• Essential for understanding translational control in health and disease.
What Happens During GCN2-mediated signaling?
Stress Sensing and GCN2 Activation
In simple terms: When a cell runs low on amino acids or encounters other stresses, GCN2 detects this and switches on.
GCN2 is activated by stress signals such as amino acid starvation, which leads to the accumulation of uncharged tRNAs that bind to the histidyl-tRNA synthetase-like domain of GCN2, relieving autoinhibition. Additionally, ribosome collisions caused by translation stress or nitric oxide exposure recruit GCN2 and trigger its activation through a ribosome-associated quality control mechanism. Mitochondrial injury can also activate GCN2 as part of the integrated stress response. Structural studies have revealed that the pseudokinase domain of GCN2 plays a regulatory role in controlling kinase activity.
eIF2alpha Phosphorylation and Translational Attenuation
In simple terms: Once active, GCN2 puts a chemical tag on a key translation factor, which slows down general protein production.
Activated GCN2 phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) at serine 51. This phosphorylation inhibits the guanine nucleotide exchange factor eIF2B, reducing the formation of the ternary complex and thereby attenuating global translation initiation. This translational brake conserves resources and allows the cell to reprogram gene expression.
Selective Translation of Stress-Responsive mRNAs
In simple terms: While most protein production stops, a few special proteins are made to help the cell cope.
Phosphorylation of eIF2alpha selectively enhances the translation of mRNAs containing upstream open reading frames (uORFs), such as ATF4, which encodes a transcription factor that drives the integrated stress response. This selective translation allows the cell to produce proteins that promote adaptation, such as those involved in amino acid synthesis and antioxidant responses.
Downstream Signaling and Cell Fate Decisions
In simple terms: The stress response can either help the cell survive or, if the stress is too severe, trigger cell death.
The GCN2-eIF2alpha-ATF4 axis regulates downstream targets that control cell survival, apoptosis, and senescence. For example, in the context of Salmonella genotoxin-induced mitochondrial injury, GCN2 activation contributes to the proinflammatory senescence-associated secretory phenotype. In cancer cells, GCN2 signaling can promote adaptation to nutrient stress, but excessive or prolonged activation may lead to cell death. The balance between survival and death is influenced by cross-talk with mTORC1 and other signaling pathways.
Key Genes Involved in GO:0140469 GCN2-mediated signaling
The following genes and proteins are core components or regulators of GCN2-mediated signaling, with established roles in the pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF2AK4 (GCN2) | Serine/threonine kinase that initiates the pathway by phosphorylating eIF2alpha. | Primary target for knockout, point mutation, and structural studies. |
| EIF2S1 (eIF2alpha) | Substrate of GCN2; phosphorylation at Ser51 inhibits global translation. | Key readout for pathway activation; point mutation (S51A) blocks signaling. |
| ATF4 | Transcription factor selectively translated upon eIF2alpha phosphorylation; drives ISR gene expression. | Marker of pathway activation; knockout models reveal downstream effects. |
| GCN1 | Ribosome collision sensor that activates GCN2. | Knockout reduces GCN2 activation by collisions. |
| GCN20 | Partner of GCN1 in ribosome collision sensing. | Potential target for disrupting stress sensing. |
| IMPACT | Negative regulator of GCN2; pseudokinase domain interactions. | Knockout increases GCN2 activity. |
| mTORC1 | Senses amino acids and cross-talks with GCN2. | Inhibition or activation modulates GCN2 signaling. |
| PABP | Poly(A)-binding protein involved in cap-independent translation during immunity. | Links GCN2 pathway to pattern-triggered immunity. |
| DDIT3 (CHOP) | Pro-apoptotic transcription factor induced downstream of ATF4. | Marker of ER stress and ISR-induced apoptosis. |
| PPP1R15A (GADD34) | Regulatory subunit of PP1 phosphatase that dephosphorylates eIF2alpha. | Feedback regulator; knockout prolongs signaling. |
| PPP1R15B (CReP) | Constitutive eIF2alpha phosphatase subunit. | Balances basal eIF2alpha phosphorylation. |
| EIF2B | Guanine nucleotide exchange factor inhibited by phosphorylated eIF2alpha. | Target for modulating translation recovery. |
| ASNS | Asparagine synthetase induced by ATF4; supports survival under amino acid stress. | Readout of GCN2-dependent adaptation. |
| VEGFA | Angiogenic factor regulated by ISR in cancer. | Potential link to GCN2 in tumor microenvironment. |
| NOS2 | Nitric oxide synthase; NO induces ribosome collisions and GCN2 activation. | Model for NO-induced stress. |
| WNT signaling components | Regulate glutamine catabolism and GCN2 activation in bone. | Cross-talk with developmental pathways. |
How Is GCN2-mediated signaling Regulated?
GCN2-mediated signaling is tightly regulated at multiple levels. The pseudokinase domain of GCN2 autoinhibits kinase activity, and ligand binding (e.g., uncharged tRNA) or ribosome collisions relieve this inhibition. The protein IMPACT negatively regulates GCN2 by interacting with its pseudokinase domain. Phosphorylation of eIF2alpha is reversed by phosphatases containing PPP1R15A (GADD34) or PPP1R15B (CReP), providing feedback termination. Cross-talk with mTORC1, which senses amino acids such as glutamine, modulates GCN2 activity and the integrated stress response. Additionally, nitric oxide-induced ribosome collisions activate GCN2 as part of a ribosomal surveillance mechanism.
GCN2-mediated signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF2AK4 (GCN2) | Cancer, cardiotoxicity, metabolic disorders | Knockout and point-mutation cell lines; xenograft models |
| EIF2S1 (eIF2alpha) | Neurodegeneration, cancer, ISR-related diseases | S51A knock-in mice; phospho-mimetic mutants |
| ATF4 | Metabolic stress, cancer, inflammation | Knockout and overexpression models |
| IMPACT | Regulation of GCN2 in cancer and development | Knockout and tagged knock-in for interaction studies |
| PPP1R15A (GADD34) | Protein misfolding diseases, cancer | Knockout and overexpression models |
Cancer and Chemoresistance
GCN2-mediated signaling supports cancer cell survival under nutrient deprivation and hypoxia by attenuating translation and promoting adaptive gene expression. In some contexts, GCN2 activation contributes to chemoresistance, while in others it promotes apoptosis. Targeting GCN2 or its downstream effectors is being explored as a therapeutic strategy.
Cardiotoxicity
Ponatinib, a tyrosine kinase inhibitor used in leukemia, induces cardiotoxicity through activation of the integrated stress response, including GCN2-mediated eIF2alpha phosphorylation. This highlights the pathway as a mediator of drug-induced cardiac damage and a potential target for cardioprotection.
Inflammatory and Infectious Diseases
GCN2 signaling is activated by mitochondrial injury caused by Salmonella genotoxin, leading to a proinflammatory senescence-associated secretory phenotype. In plants, GCN2 is involved in pattern-triggered immunity through cap-independent translation. These findings link GCN2 to host defense and inflammation.
Metabolic and Bone Disorders
GCN2 senses glutamine and other amino acids, integrating metabolic status with the ISR. In bone, increased glutamine catabolism mediated by WNT signaling activates GCN2 to promote bone anabolism. Dysregulation may contribute to metabolic bone diseases.
From GCN2-mediated signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GCN2 kinase activity require its pseudokinase domain? | Point mutation (kinase-dead or pseudokinase mutant) in EIF2AK4 |
| What is the role of eIF2alpha phosphorylation in stress adaptation? | Knock-in of non-phosphorylatable eIF2alpha (S51A) |
| How does GCN2 respond to ribosome collisions? | Knockout of GCN1 or GCN20 combined with ribosome profiling |
| Can GCN2 inhibition protect against cardiotoxicity? | Cardiomyocyte knockout or overexpression models treated with ponatinib |
| What are the downstream targets of ATF4 in cancer? | ATF4 knockout and overexpression in cancer cell lines |
| How does mTORC1 cross-talk with GCN2? | mTORC1 knockout or rapamycin treatment in GCN2 reporter cells |
How to Study the GCN2-mediated signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation efficiency | Global translation changes and ribosome collisions |
| RNA-seq | mRNA abundance and splicing | Transcriptional responses to GCN2 activation |
| Phospho-eIF2alpha immunoblot | eIF2alpha phosphorylation at Ser51 | Pathway activation status |
| Phosphoproteomics | Global phosphorylation changes | Identifying novel GCN2 substrates |
| CRISPR knockout screens | Gene essentiality and pathway modifiers | Discovery of regulators of GCN2 signaling |
| CRISPR activation (CRISPRa) | Overexpression of target genes | Gain-of-function studies for pathway components |
| Proximity labeling (BioID) | Protein-protein interactions | Mapping GCN2 interactome |
| Live-cell imaging | Real-time translation and stress granule dynamics | Visualizing pathway activation |
Ribosome Profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy and translation efficiency genome-wide, revealing how GCN2 activation alters global and gene-specific translation. It is particularly useful for detecting ribosome collisions and uORF-mediated regulation.
RNA Sequencing (RNA-seq)
RNA-seq quantifies changes in mRNA abundance and splicing, providing insights into transcriptional responses downstream of GCN2-ATF4 signaling. It complements Ribo-seq by distinguishing transcriptional from translational regulation.
Phospho-specific Immunoblotting and Proteomics
Antibodies against phosphorylated eIF2alpha (Ser51) are standard for monitoring GCN2 pathway activation. Mass spectrometry-based phosphoproteomics can identify additional substrates and signaling nodes.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate GCN2-mediated signaling under stress conditions. These screens are powerful for discovering novel regulators and therapeutic targets.
How CRISPR Can Be Used to Study GO:0140469 GCN2-mediated signaling
Knockout
CRISPR knockout of EIF2AK4 (GCN2) abolishes stress-induced eIF2alpha phosphorylation, allowing researchers to test the requirement for GCN2 in specific stress responses. Knockout of downstream effectors such as ATF4 or PPP1R15A reveals their contributions to cell fate.
Point Mutation
Point mutations can be introduced to dissect kinase activity, such as kinase-dead mutants of GCN2 or non-phosphorylatable eIF2alpha (S51A). These models are essential for distinguishing phosphorylation-dependent from independent functions.
Knock-in
Knock-in of tagged GCN2 (e.g., GFP or HA) enables visualization and immunoprecipitation of the endogenous protein. Knock-in of reporter genes under stress-responsive promoters allows real-time monitoring of pathway activity.
Overexpression
Overexpression of wild-type or mutant GCN2, eIF2alpha, or ATF4 can amplify pathway signaling and reveal gain-of-function phenotypes. This approach is useful for studying downstream effects and for drug screening.
How EDITGENE Supports GCN2-mediated signaling Research
Researchers studying GCN2-mediated signaling-related genes often need to determine whether a candidate gene is causally involved in stress sensing, translational control, or disease progression. Precise genetic models are essential to move from correlation to causation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for GCN2-mediated signaling research.
Frequently Asked Questions About GCN2-mediated signaling
What is GCN2-mediated signaling?
GCN2-mediated signaling (GO:0140469) is a cellular stress response pathway in which the kinase GCN2 (EIF2AK4) is activated by amino acid starvation and other stresses, leading to phosphorylation of eIF2alpha and translational reprogramming.
What genes are involved in GCN2-mediated signaling?
Key genes include EIF2AK4 (GCN2), EIF2S1 (eIF2alpha), ATF4, GCN1, GCN20, IMPACT, and PPP1R15A (GADD34).
How is GCN2 activated?
GCN2 is activated by uncharged tRNAs during amino acid starvation, by ribosome collisions, and by mitochondrial stress.
What is the role of eIF2alpha in GCN2 signaling?
eIF2alpha is the substrate of GCN2; its phosphorylation at Ser51 inhibits global translation and promotes selective translation of stress-responsive mRNAs like ATF4.
What diseases are associated with GCN2-mediated signaling?
It is implicated in cancer, cardiotoxicity, inflammatory diseases, and metabolic disorders.
How can I study GCN2-mediated signaling in the lab?
Common methods include Ribo-seq, RNA-seq, phospho-eIF2alpha immunoblotting, and CRISPR screens.
What is the integrated stress response?
The ISR is a cellular pathway that responds to various stresses by phosphorylating eIF2alpha; GCN2 is one of its four main kinases.
Can GCN2 be targeted therapeutically?
Yes, GCN2 inhibitors are being explored for cancer and cardiotoxicity, and its pseudokinase domain offers a potential drug target.
What is the difference between GCN2 and mTORC1?
GCN2 is activated by amino acid starvation to inhibit translation, while mTORC1 promotes translation when amino acids are abundant; they cross-talk.
How does GCN2 sense ribosome collisions?
GCN1 and GCN20 recognize collided ribosomes and activate GCN2, linking translation quality control to stress signaling.
Conclusion
GCN2-mediated signaling (GO:0140469) is a fundamental stress-responsive pathway that coordinates translation and gene expression to determine cell fate. Its roles in cancer, cardiotoxicity, inflammation, and metabolism make it a compelling target for basic and translational research. Advances in CRISPR-based models and functional genomics are accelerating our understanding of this pathway and its therapeutic potential.
References
- 1. Wu CC et al.. 2020. Ribosome Collisions Trigger General Stress Responses to Regulate Cell Fate.. Cell 182(2):404-416.e14 PMID: 32610081
- 2. Wang J et al.. 2022. PABP/purine-rich motif as an initiation module for cap-independent translation in pattern-triggered immunity.. Cell 185(17):3186-3200.e17 PMID: 35907403
- 3. Yan G et al.. 2024. Integrated Stress Response Potentiates Ponatinib-Induced Cardiotoxicity.. Circ Res 134(5):482-501 PMID: 38323474
- 4. Figlia G et al.. 2025. mTORC1 senses glutamine and other amino acids through GCN2.. EMBO J 44(17):4825-4866 PMID: 40691417
- 5. Liu Y et al.. 2026. Structural basis for pseudokinase-mediated regulation of GCN2 in the integrated stress response.. Proc Natl Acad Sci U S A 123(5):e2526598123 PMID: 41615758
- 6. Chen HY et al.. 2024. Mitochondrial injury induced by a Salmonella genotoxin triggers the proinflammatory senescence-associated secretory phenotype.. Nat Commun 15(1):2778 PMID: 38555361
- 7. Karner CM et al.. 2015. Increased glutamine catabolism mediates bone anabolism in response to WNT signaling.. J Clin Invest 125(2):551-62 PMID: 25562323
- 8. Ryder L et al.. 2023. Nitric oxide-induced ribosome collision activates ribosomal surveillance mechanisms.. Cell Death Dis 14(7):467 PMID: 37495584
